Two mucosal-parenteral schedules to coadminister a multiantigenic formulation against HIV-1 in Balb/c mice

International Immunopharmacology

Volumn 12, Issue 3, 2012, Pages 487-493

  Iglesias, Enrique ^a   García, Daymir ^a   Márquez, Gabriel ^a   Prieto, Yayrí C ^a   Sánchez, Jorge ^a   Trimiño, Lian ^a   Soria, Yordanka ^a   García, Darien ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

Adjuvants; Cellular immune responses; HIV vaccines; Mucosal immune responses

Indexed keywords

CELLULAR RESPONSE 3; GAMMA INTERFERON; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; PLACEBO; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DOSAGE SCHEDULE COMPARISON; DRUG FORMULATION; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; INOCULATION; LYMPHOCYTE PROLIFERATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SECRETORY CELL; SEROCONVERSION; SPLEEN CELL; TH1 CELL; VAGINA;

ADMINISTRATION, INTRANASAL; AIDS VACCINES; ANIMALS; ANTIGENS, CD8; ANTIGENS, VIRAL; CHEMISTRY, PHARMACEUTICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; HEPATITIS B CORE ANTIGENS; HIV ANTIBODIES; HIV-1; IMMUNITY, MUCOSAL; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; INTERFERON-GAMMA; MICE; MICE, INBRED BALB C; VAGINA;

EID: 84857369347     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.12.026     Document Type: Article

References (59)

1. O.U. Kawalekar, D.J. Shedlock, and D.B. Weiner Current strategies and limitations of HIV vaccines Curr Opin Investig Drugs 11 2010 192 202
2. D.H. Barouch, and B. Korber HIV-1 vaccine development after STEP Annu Rev Med 61 2010 153 167
3. H.W. Virgin, and B.D. Walker Immunology and the elusive AIDS vaccine Nature 464 2010 224 231
4. IAVI Database of AIDS vaccine candidates in clinical trials 2011 International AIDS Vaccine Initiative (IAVI)
5. AIDSInfo HIV/AIDS clinical trials. HIV therapeutic vaccines 2011 U.S. Department of Health and Human Services Rockville
6. Anonymous HIV vaccine failure prompts Merck to halt trial Nature 449 2007 390
7. B.D. Walker, and D.R. Burton Toward an AIDS vaccine Science 320 2008 760 764 (Pubitemid 351929619)
8. UNAIDS/WHO AIDS epidemic update: December 2009 2009 Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) Geneva
9. R.S. Veazey, K.G. Mansfield, I.C. Tham, A.C. Carville, D.E. Shvetz, and A.E. Forand Dynamics of CCR5 expression by CD4(+) T cells in lymphoid tissues during simian immunodeficiency virus infection J Virol 74 2000 11001 11007 (Pubitemid 32223965)
10. S. Kewenig, T. Schneider, K. Hohloch, K. Lampe-Dreyer, R. Ullrich, and N. Stolte Rapid mucosal CD4(+) T-cell depletion and enteropathy in simian immunodeficiency virus-infected rhesus macaques Gastroenterology 116 1999 1115 1123 (Pubitemid 29203021)
11. M. Vajdy, R. Veazey, I. Tham, C. deBakker, S. Westmoreland, and M. Neutra Early immunologic events in mucosal and systemic lymphoid tissues after intrarectal inoculation with simian immunodeficiency virus J Infect Dis 184 2001 1007 1014 (Pubitemid 32955117)
12. Z. Smit-McBride, J.J. Mattapallil, M. McChesney, D. Ferrick, and S. Dandekar Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4(+) T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes J Virol 72 1998 6646 6656 (Pubitemid 28323982)
13. J.M. Harouse, A. Gettie, R.C. Tan, J. Blanchard, and C. Cheng-Mayer Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs Science 284 1999 816 819 (Pubitemid 29291349)
14. R.S. Veazey, M. DeMaria, L.V. Chalifoux, D.E. Shvetz, D.R. Pauley, and H.L. Knight Gastrointestinal tract as a major site of CD4 + T cell depletion and viral replication in SIV infection Science 280 1998 427 431 (Pubitemid 28208163)
15. J.M. Brenchley, T.W. Schacker, L.E. Ruff, D.A. Price, J.H. Taylor, and G.J. Beilman CD4 + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract J Exp Med 200 2004 749 759 (Pubitemid 39299461)
16. F. Clayton, G. Snow, S. Reka, and D.P. Kotler Selective depletion of rectal lamina propria rather than lymphoid aggregate CD4 lymphocytes in HIV infection Clin Exp Immunol 107 1997 288 292 (Pubitemid 27049254)
17. S. Mehandru, M.A. Poles, K. Tenner-Racz, A. Horowitz, A. Hurley, and C. Hogan Primary HIV-1 infection is associated with preferential depletion of CD4 + T lymphocytes from effector sites in the gastrointestinal tract J Exp Med 200 2004 761 770 (Pubitemid 39299462)
18. C.J. Miller, Q. Li, K. Abel, E.Y. Kim, Z.M. Ma, and S. Wietgrefe Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus J Virol 79 2005 9217 9227 (Pubitemid 40934833)
19. A.T. Haase Perils at mucosal front lines for HIV and SIV and their hosts Nat Rev Immunol 5 2005 783 792 (Pubitemid 41400852)
20. J.R. Lees, and D.L. Farber Generation, persistence and plasticity of CD4 T-cell memories Immunology 130 2010 463 470
21. G. Xue, L. Yu, S. Li, and X. Shen Intranasal immunization with GBS surface protein Sip and ScpB induces specific mucosal and systemic immune responses in mice FEMS Immunol Med Microbiol 58 2010 202 210
22. W. Kastenmuller, G. Gasteiger, L. Stross, D.H. Busch, and I. Drexler Cutting edge: mucosal application of a lyophilized viral vector vaccine confers systemic and protective immunity toward intracellular pathogens J Immunol 182 2009 2573 2577
23. B. Lu, Y. Huang, L. Huang, B. Li, Z. Zheng, and Z. Chen Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice Immunology 130 2010 254 261
24. D. Bumann, C. Behre, K. Behre, S. Herz, B. Gewecke, and J.E. Gessner Systemic, nasal and oral live vaccines against Pseudomonas aeruginosa: a clinical trial of immunogenicity in lower airways of human volunteers Vaccine 28 2010 707 713
25. P.A. Kozlowski, S.B. Williams, R.M. Lynch, T.P. Flanigan, R.R. Patterson, and S. Cu-Uvin Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle J Immunol 169 2002 566 574 (Pubitemid 34686180)
26. C. Bergquist, E.L. Johansson, T. Lagergard, J. Holmgren, and A. Rudin Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina Infect Immun 65 1997 2676 2684 (Pubitemid 27264094)
27. Y. Enose, M. Ui, A. Miyake, H. Suzuki, H. Uesaka, and T. Kuwata Protection by intranasal immunization of a nef-deleted, nonpathogenic SHIV against intravaginal challenge with a heterologous pathogenic SHIV Virology 298 2002 306 316 (Pubitemid 35034546)
28. M. Vajdy, B. Baudner, G. Del Giudice, and D. O'Hagan A vaccination strategy to enhance mucosal and systemic antibody and T cell responses against influenza Clin Immunol 123 2007 166 175 (Pubitemid 46590074)
29. X. Huang, L. Liu, L. Ren, C. Qiu, Y. Wan, and J. Xu Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses Vaccine 25 2007 8874 8884 (Pubitemid 350192050)
30. M. Vajdy, M. Singh, M. Ugozzoli, M. Briones, E. Soenawan, and L. Cuadra Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations Immunology 110 2003 86 94 (Pubitemid 37059676)
31. I. Srivastava, A. Goodsell, F. Zhou, Y. Sun, B. Burke, and S. Barnett Dynamics of acute and memory mucosal and systemic immune responses against HIV-1 envelope following immunizations through single or combinations of mucosal and systemic routes Vaccine 26 2008 2796 2806
32. K.S. Park, J. Lee, S.S. Ahn, Y.H. Byun, B.L. Seong, and Y.H. Baek Mucosal immunity induced by adenovirus-based H5N1 HPAI vaccine confers protection against a lethal H5N2 avian influenza virus challenge Virology 395 2009 182 189
33. E. Iglesias, M. Ruiz, Y. Carrazana, L.J. Cruz, A. Aguilar, and V. Jimenez Chimeric proteins containing HIV-1 T cell epitopes: expression in E. coli, purification and induction of antibodies in mice J Biochem Mol Biol Biophys 5 2001 109 120
34. E. Iglesias, D. Garcia, Y. Carrazana, J.C. Aguilar, A. Sanchez, and L. Gorobaya Anti-HIV-1 and anti-HBV immune responses in mice after parenteral and nasal co-administration of a multiantigenic formulation Curr HIV Res 6 2008 452 460
35. E. Iglesias, R. Thompson, Y. Carrazana, Y. Lobaina, D. Garcia, and J. Sanchez Coinoculation with hepatitis B surface and core antigen promotes a Th1 immune response to a multiepitopic protein of HIV-1 Immunol Cell Biol 84 2006 174 183 (Pubitemid 43344671)
36. Y. Lobaina, D. Garcia, N. Abreu, V. Muzio, and J.C. Aguilar Mucosal immunogenicity of the hepatitis B core antigen Biochem Biophys Res Commun 300 2003 745 750 (Pubitemid 36277661)
37. E. Hardy, E. Martinez, D. Diago, R. Diaz, D. Gonzalez, and L. Herrera Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris J Biotechnol 77 2000 157 167 (Pubitemid 30055332)
38. T.R. Mosmann, H. Cherwinski, M.W. Bond, M.A. Giedlin, and R.L. Coffman Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins J Immunol 136 1986 2348 2357 (Pubitemid 16136806)
39. P. Sideras, S. Bergstedt-Lindqvist, and E. Severinson Partial biochemical characterization of IgG1-inducing factor Eur J Immunol 15 1985 593 598 (Pubitemid 15022763)
40. C.M. Snapper, and W.E. Paul Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production Science 236 1987 944 947 (Pubitemid 17107942)
41. E.S. Vitetta, J. Ohara, C.D. Myers, J.E. Layton, P.H. Krammer, and W.E. Paul Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1 J Exp Med 162 1985 1726 1731 (Pubitemid 16195372)
42. C. Devito, K. Broliden, R. Kaul, L. Svensson, K. Johansen, and P. Kiama Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells J Immunol 165 2000 5170 5176
43. M. Knuf, F. Zepp, C.U. Meyer, P. Habermehl, L. Maurer, and H.M. Burow Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months Eur J Pediatr 169 2010 925 933
44. I.F. Cook, D. Pond, and G. Hartel Comparative reactogenicity and immunogenicity of 23 valent pneumococcal vaccine administered by intramuscular or subcutaneous injection in elderly adults Vaccine 25 2007 4767 4774 (Pubitemid 46818616)
45. R. Edelman, S.S. Wasserman, S.A. Bodison, J.G. Perry, M. O'Donnoghue, and L.J. DeTolla Phase II safety and immunogenicity study of type F botulinum toxoid in adult volunteers Vaccine 21 2003 4335 4347 (Pubitemid 37138700)
46. E.H. Fleischmann, J. Kruppenbacher, H.L. Bock, and M. Weber Active immunization against hepatitis A in dialysis patients Nephrol Dial Transplant 17 2002 1825 1828 (Pubitemid 35174297)
47. A. Mark, R.M. Carlsson, and M. Granstrom Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents Vaccine 17 1999 2067 2072 (Pubitemid 29172379)
48. R.M. Carlsson, B.A. Claesson, H. Kayhty, U. Selstam, and S. Iwarson Studies on a Hib-tetanus toxoid conjugate vaccine: effects of co-administered tetanus toxoid vaccine, of administration route and of combined administration with an inactivated polio vaccine Vaccine 18 1999 468 478 (Pubitemid 29462603)
49. L. Valor, J. Navarro, J. Carbone, C. Rodriguez-Sainz, J. Gil, and F. Lopez Immunization with an HIV-1 immunogen induces CD4 + and CD8 + HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy Vaccine 26 2008 2738 2745
50. M. Bomsel, D. Tudor, A.S. Drillet, A. Alfsen, Y. Ganor, and M.G. Roger Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges Immunity 34 2011 269 280
51. G.J. Gorse, E.E. Otto, D.C. Powers, G.W. Chambers, C.S. Eickhoff, and F.K. Newman Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly J Infect Dis 173 1996 285 290 (Pubitemid 26042426)
52. J.J. Treanor, H.R. Mattison, G. Dumyati, A. Yinnon, S. Erb, and D. O'Brien Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly Ann Intern Med 117 1992 625 633
53. G.J. Gorse, M.J. Campbell, E.E. Otto, D.C. Powers, G.W. Chambers, and F.K. Newman Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine J Infect Dis 172 1995 1 10
54. V. Appay, and D. Sauce Immune activation and inflammation in HIV-1 infection: causes and consequences J Pathol 214 2008 231 241 (Pubitemid 351160160)
55. K. Fujihashi, and H. Kiyono Mucosal immunosenescence: new developments and vaccines to control infectious diseases Trends Immunol 30 2009 334 343
56. A.L. Ferre, P.W. Hunt, J.W. Critchfield, D.H. Young, M.M. Morris, and J.C. Garcia Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control Blood 113 2009 3978 3989
57. A.L. Ferre, P.W. Hunt, D.H. McConnell, M.M. Morris, J.C. Garcia, and R.B. Pollard HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4 + T-cell responses J Virol 84 2010 11020 11029
58. S.J. Potter, C. Lacabaratz, O. Lambotte, S. Perez-Patrigeon, B. Vingert, and M. Sinet Preserved central memory and activated effector memory CD4 + T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study J Virol 81 2007 13904 13915 (Pubitemid 350247883)
59. M.R. Hilleman Overview of the pathogenesis, prophylaxis and therapeusis of viral hepatitis B, with focus on reduction to practical applications Vaccine 19 2001 1837 1848 (Pubitemid 32178329)